The Multifaceted Roles of Aldolase A in Cancer: Glycolysis, Cytoskeleton, Translation and Beyond

Overview

Journal Hum Cell

Publisher Springer

Date 2025 Jan 14

PMID 39808355

Authors

Shiyi Yu

Yaji Xue

Yongli Chen

Yuanye Cao

Yawen Yang

Xiaoyu Ge

Xinting Cai

Affiliations

Soon will be listed here.

Abstract

Cancer, a complicated disease characterized by aberrant cellular metabolism, has emerged as a formidable global health challenge. Since the discovery of abnormal aldolase A (ALDOA) expression in liver cancer for the first time, its overexpression has been identified in numerous cancers, including colorectal cancer (CRC), breast cancer (BC), cervical adenocarcinoma (CAC), non-small cell lung cancer (NSCLC), gastric cancer (GC), hepatocellular carcinoma (HCC), pancreatic cancer adenocarcinoma (PDAC), and clear cell renal cell carcinoma (ccRCC). Moreover, ALDOA overexpression promotes cancer cell proliferation, invasion, migration, and drug resistance, and is closely related to poor prognosis of patients with cancer. Although originally discovered to promote cancer initiation and progression by accelerating glycolysis, recent studies have revealed its atypical roles in cancer, e.g., adjusting cytoskeleton, regulating mRNA translation, cell signaling pathways, and DNA repair. These aforementioned findings challenge our traditional understanding of ALDOA function and prompt deep exploration of its novel roles in tumor biology. The present review summarizes the latest insights into ALDOA as a potential cancer biomarker and therapeutic target.

References

Kresge N, Simoni R, Hill R . Otto Fritz Meyerhof and the elucidation of the glycolytic pathway. J Biol Chem. 2005; 280(4):e3. View

Gamblin S, Cooper B, Millar J, Davies G, Littlechild J, Watson H . The crystal structure of human muscle aldolase at 3.0 A resolution. FEBS Lett. 1990; 262(2):282-6. DOI: 10.1016/0014-5793(90)80211-z. View

Cooper S, Leonard G, McSweeney S, Thompson A, Naismith J, Qamar S . The crystal structure of a class II fructose-1,6-bisphosphate aldolase shows a novel binuclear metal-binding active site embedded in a familiar fold. Structure. 1996; 4(11):1303-15. DOI: 10.1016/s0969-2126(96)00138-4. View

Siebers B, Brinkmann H, Dorr C, Tjaden B, Lilie H, van der Oost J . Archaeal fructose-1,6-bisphosphate aldolases constitute a new family of archaeal type class I aldolase. J Biol Chem. 2001; 276(31):28710-8. DOI: 10.1074/jbc.M103447200. View

Thomson G, Howlett G, Ashcroft A, Berry A . The dhnA gene of Escherichia coli encodes a class I fructose bisphosphate aldolase. Biochem J. 1998; 331 ( Pt 2):437-45. PMC: 1219373. DOI: 10.1042/bj3310437. View

Prasad C, Gupta S, Kumar H, Tiwari M . Evolutionary and functional analysis of fructose bisphosphate aldolase of plant parasitic nematodes. Bioinformation. 2013; 9(1):1-8. PMC: 3563409. DOI: 10.6026/97320630009001. View

Plater A, Zgiby S, Thomson G, Qamar S, Wharton C, Berry A . Conserved residues in the mechanism of the E. coli Class II FBP-aldolase. J Mol Biol. 1999; 285(2):843-55. DOI: 10.1006/jmbi.1998.2376. View

Sauve V, Sygusch J . Molecular cloning, expression, purification, and characterization of fructose-1,6-bisphosphate aldolase from Thermus aquaticus. Protein Expr Purif. 2001; 21(2):293-302. DOI: 10.1006/prep.2000.1380. View

Tolan D, Niclas J, Bruce B, Lebo R . Evolutionary implications of the human aldolase-A, -B, -C, and -pseudogene chromosome locations. Am J Hum Genet. 1987; 41(5):907-24. PMC: 1684339. View

10.

Arakaki T, Pezza J, Cronin M, Hopkins C, Zimmer D, Tolan D . Structure of human brain fructose 1,6-(bis)phosphate aldolase: linking isozyme structure with function. Protein Sci. 2004; 13(12):3077-84. PMC: 2287316. DOI: 10.1110/ps.04915904. View

11.

Kukita A, Yoshida M, Fukushige S, Sakakibara M, Joh K, Mukai T . Molecular gene mapping of human aldolase A (ALDOA) gene to chromosome 16. Hum Genet. 1987; 76(1):20-6. DOI: 10.1007/BF00283044. View

12.

Beutler E, Scott S, Bishop A, MARGOLIS N, Matsumoto F, KUHL W . Red cell aldolase deficiency and hemolytic anemia: a new syndrome. Trans Assoc Am Physicians. 1973; 86:154-66. View

13.

Kishi H, Mukai T, Hirono A, Fujii H, Miwa S, Hori K . Human aldolase A deficiency associated with a hemolytic anemia: thermolabile aldolase due to a single base mutation. Proc Natl Acad Sci U S A. 1987; 84(23):8623-7. PMC: 299598. DOI: 10.1073/pnas.84.23.8623. View

14.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

15.

SCHAPIRA F, DREYFUS J, SCHAPIRA G . ANOMALY OF ALDOLASE IN PRIMARY LIVER CANCER. Nature. 1963; 200:995-7. DOI: 10.1038/200995a0. View

16.

Asaka M, Nagase K, Miyazaki T, Alpert E . Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases. Gastroenterology. 1983; 84(1):155-60. View

17.

Asaka M, Kimura T, Meguro T, Kato M, Kudo M, Miyazaki T . Alteration of aldolase isozymes in serum and tissues of patients with cancer and other diseases. J Clin Lab Anal. 1994; 8(3):144-8. DOI: 10.1002/jcla.1860080306. View

18.

Ojika T, Imaizumi M, Abe T, Kato K . Immunochemical and immunohistochemical studies on three aldolase isozymes in human lung cancer. Cancer. 1991; 67(8):2153-8. DOI: 10.1002/1097-0142(19910415)67:8<2153::aid-cncr2820670825>3.0.co;2-z. View

19.

Mhawech-Fauceglia P, Wang D, Kesterson J, Beck A, Bentley K, Shroff S . Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology. Histopathology. 2011; 59(5):1015-8. PMC: 5047381. DOI: 10.1111/j.1365-2559.2011.03944.x. View

20.

Jiang Z, Wang X, Li J, Yang H, Lin X . Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer. J Cell Mol Med. 2018; 22(9):4377-4386. PMC: 6111871. DOI: 10.1111/jcmm.13732. View